Evidence map›Paper›PMID 28160221›Full record

ArticleRadiological physics and technology2017

Simultaneous detection of hepatocellular carcinoma and vessel thrombus by using SPIO-enhanced B-TFE with the T

Masayuki Kanamoto, Tosiaki Miyati, Kazuki Terashima, Kei Katahira, Ryoji Ida, Daisaku Suga, Nobukazu Fuwa

Abstract read
PubMed Publisher
In one paragraph

Article in Radiological physics and technology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Masayuki KanamotoDepartment of Radiology, University of Fukui Hospital, 23-3 Shimoaizuki, Matsuoka, Eiheiji-tyo, Yoshida-gun, Fukui, 910-1193, Japan. kanamo@u-fukui.ac.jp.
Tosiaki MiyatiDivision of Health Sciences, Graduate School of Medical Science, Kanazawa University, 5-11-80 Kodatsuno, Kanazawa, Ishikawa, 920-0942, Japan.
Kazuki TerashimaDepartment of Radiology, Hyogo Ion Beam Medical Center, 1-2-1 Kouto, Shingutyo, Tatsuno, Hyogo, 679-5165, Japan.
Kei KatahiraDepartment of Radiation Technology, Hyogo Ion Beam Medical Center, 1-2-1 Kouto, Shingutyo, Tatsuno, Hyogo, 679-5165, Japan.
Ryoji IdaDepartment of Radiation Technology, Hyogo Ion Beam Medical Center, 1-2-1 Kouto, Shingutyo, Tatsuno, Hyogo, 679-5165, Japan.
Daisaku SugaHyogo Ion Beam Medical Support, 1-2-1 Kouto, Shingutyo, Tatsuno, Hyogo, 679-5165, Japan.
Nobukazu FuwaDepartment of Radiation Oncology, Japanese Red Cross Ise Hospital, 1-471-2 Funase, Ise, Mie, 516-8512, Japan.
Hyogo Ion Beam Medical Center · JPIse Red Cross Hospital · JPKanazawa University · JPUniversity of Fukui Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to compare between superparamagnetic iron oxide (SPIO)-enhanced three-dimensional balanced turbo field-echo (B-TFE) sequence with T

Indexed as

AdultAgedAged, 80 and overBlood VesselsCarcinoma, HepatocellularDiffusion Magnetic Resonance ImagingFemaleFerric CompoundsHumansLiver NeoplasmsMagnetsMaleMiddle AgedThrombosisFerric Compoundsferric oxideBalanced turbo field echo (B-TFE)Hepatocellular carcinoma (HCC)Magnetic resonance imaging (MRI)Superparamagnetic iron oxide (SPIO)T2 preparation pulse (T2 prep)Tumor thrombus

Identifiers

PMID28160221
OpenAlexW2584358166

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.